Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Income from Continuing Operations (2022 - 2025)

CervoMed's Income from Continuing Operations history spans 9 years, with the latest figure at 7725412.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 62.64% year-over-year to 7725412.0; the TTM value through Sep 2025 reached 25576099.0, down 114.15%, while the annual FY2024 figure was 16289704.0, 114.52% down from the prior year.
  • Income from Continuing Operations for Q3 2025 was 7725412.0 at CervoMed, down from 6248148.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1390915.0 in Q1 2023 and bottomed at 7725412.0 in Q3 2025.
  • The 4-year median for Income from Continuing Operations is 4190501.0 (2022), against an average of 4025589.13.
  • The largest annual shift saw Income from Continuing Operations soared 69.27% in 2023 before it crashed 184.05% in 2024.
  • A 4-year view of Income from Continuing Operations shows it stood at 5922423.0 in 2022, then soared by 60.12% to 2361798.0 in 2023, then crashed by 184.05% to 6708640.0 in 2024, then decreased by 15.16% to 7725412.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Income from Continuing Operations are 7725412.0 (Q3 2025), 6248148.0 (Q2 2025), and 4893899.0 (Q1 2025).